Acquiring Groupe Corneal's aesthetic division will expand Allergan's marketing rights for the dermal filler product Juvederm as well as a range of fillers, from the U.S., Canada and Australia to include all countries worldwide. Allergan will also gain control of all manufacturing, future development and intellectual property related to Juvederm.